Neuralstem Inc (NYSE MKT LLC:CUR)
| 1.39 Data as of Jun 18 |  -0.03 / -2.11%Today’s Change | 0.42 Today|||52-Week Range 1.96 | +27.52% Year-to-Date |
Latest CUR News | Press Releases
No recent news for Neuralstem Inc.
Today’s Trading
| Previous close | 1.42 |
| Today’s open | 1.40 |
| Day’s range | -- - -- |
| Volume | 282,645 |
| Average volume (3 months) | 490,682 |
| Market cap | $95.6M |
| Dividend yield | -- |
Data as of 4:00pm ET, 06/18/2013
Growth & Valuation
| Earnings growth (last year) | +34.62% |
| Earnings growth (this year) | -8.82% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +4.37% |
| P/E ratio | NM |
| Price/Sales | 155.47 |
| Price/Book | 13.59 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BCRXBioCryst Pharmaceuti... | +0.09 | +5.29% |
| PSDVpSivida Corp | +0.12 | +3.23% |
| AGENAgenus Inc | +0.03 | +0.80% |
| PTIEPain Therapeutics In... | +0.01 | +0.42% |
Data as of 4:00pm ET, 06/18/2013
Financials
| Next reporting date | August 15, 2013 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $407.7K |
| Annual profit (last year) | -$10.1M |
| Net profit margin | -2,482.54% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Scientific Officer Karl Y. Johe, PhD |
President, CEO, CFO, Director & Legal Counsel I. Richard Garr |
Corporate headquarters Rockville, Maryland |
Forecasts
